Showing results (131-140 of 412) with videos related to

Sort By:
Pageof 42
Leukemia Research|July 2, 2013
Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studiesSamir Dalia, Julio Chavez, Jorge J Castillo, et al.
Cells|October 27, 2022
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström MacroglobulinemiaJavier Muñoz, Jonas Paludo, Shayna Sarosiek, et al.
Hematology/Oncology Clinics of North America|August 13, 2023
Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Caitlin Gribbin, Jorge J Castillo, et al.
Leukemia Research|July 24, 2014
Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studiesEmmanuel Apor, Jennifer O'Brien, Merin Stephen, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 27, 2026
SOHO State-of-the-Art Updates and Next Questions: Current Approach to Waldenström MacroglobulinemiaPrashant Kapoor, Udit Yadav, Camille Edwards, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2022
When a Monoclonal Gammopathy Is Not Multiple MyelomaBenjamin Derman, Jorge J Castillo, Shayna Sarosiek, et al.
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Blood|November 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemiaJorge J Castillo, Andrew R Branagan, David Sermer, et al.
Blood|December 8, 2018
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J Castillo, Gilad Itchaki, Jonas Paludo, et al.
Blood|July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's MacroglobulinemiaVéronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.
Pageof 42